Fig. 2From: Inhaled granulocyte-macrophage colony stimulating factor for mild-to-moderate autoimmune pulmonary alveolar proteinosis - a six month phase II randomized study with 24 months of follow-upFlow diagram of the study cohort. aPAP: autoimmune pulmonary alveolar proteinosis; GM-CSF: granulocyte-macrophage colony stimulating factorBack to article page